This article describes the need for real-time information about high-risk psychoactive medicines, and the development of SafeScript.

Beliefs about the usefulness of initiatives to reduce opioid prescribing in clinical practice and autonomy in prescribing may be important considerations in driving compliance.

The need for medicinal and procedural treatment for many conditions can be reduced if proficiency in exercise prescription is developed.

This paper provides a summary of the evidence supporting the use of PCSK9 inhibitors and siRNA, with relevant recommendations from consensus guidelines.

The aim of this paper is to provide an update on advances in cardiac implantable electronic devices technology and how this applies to managing patients.

Two patients presented with a history of widespread itch with blisters (bullae).